Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Biju Parekkadan serves as an Assistant Professor of Surgery at Massachusetts General Hospital/Harvard Medical School, and is an affiliated faculty member of the Harvard Stem Cell Institute and the Broad Institute. Dr. Parekkadan also has experience in developing commercial products for life science and education, including a new stem cell therapy (Sentien Biotechnologies, Inc), an augmented/virtual reality app (Zyndo, LLC), and the science-fiction trilogy Sumeria (Dream Novels, LLC).
In 2012, he was recognized by Harvard Medical School with a Young Mentor of the Year Award and by the White House with a Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor given by the US government for early careeekkr investigators. He received a B.S. in Biomedical Engineering from Rutgers University (2003) and a Ph.D. in Chemical and Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (2008).
Dr. Parekkadan’s laboratory is focused on cell and genetic engineering to create new medicines and model systems. His laboratory has expertise in engineering cell and gene therapeutics for translation. In complement to new therapeutic platforms, his group also applies engineering methods to create new assays for biomarker and drug discovery.
Jack M Milwid, Matthew Li, Jungwoo Lee, Martin L Yarmush and Biju Parekkadan
Research Article: J Bone Marrow Res 2013, 1:113